Dynacure develops and markets antisense oligonucleotide-based drugs for the treatment of orphan disorders.
Business Model:
Revenue: $0
Employees: 11-50
Address: 850, Boulevard Sébastien Brant
City: Illkirch-Graffenstaden
State: alsace
Zip: 67400
Country: FR
Dynacure develops and markets antisense oligonucleotide-based drugs for the treatment of orphan disorders.
Contact Phone:
Contact Email:
Listed Exchange:
NASDAQ
Ticker Symbol:
DYCU
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 4/2020 | Series C | $55M |
Perceptive Advisors Bpifrance Large Venture Andera Partners Kurma Partners Pontifax |
11/2016 | Seed Round | 2 | $3.6M |
Kurma Partners Idinvest Partners Kurma Partners |
7/2018 | Series A | 5 | $55.2M |
Pontifax Kurma Partners Bpifrance Andera Partners Andera Partners Kurma Partners Idinvest Partners Pontifax Kurma Partners Bpifrance Andera Partners Andera Partners Kurma Partners |
4/2020 | Series C | 6 | $54.2M |
Andera Partners Bpifrance Kurma Partners Perceptive Advisors Pontifax Tekla Capital Management Andera Partners Bpifrance Kurma Partners Perceptive Advisors Pontifax Tekla Capital Management |
7/2018 | Series C | $55M |
Andera Partners Perceptive Advisors Bpifrance Large Venture Tekla Capital Management LLC Andera Partners Perceptive Advisors Bpifrance Large Venture Tekla Capital Management LLC |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|